徳島大学 / 教育研究者総覧 --- 峯田あゆか

検索:

徳島大学 ⟩ 大学院医歯薬学研究部 ⟩ 医学域 ⟩ 先端医学教育研究プロジェクト ⟩
徳島大学 ⟩ 大学院医歯薬学研究部 ⟩ 医学域 ⟩ 医科学部門 ⟩ 外科系 ⟩ 産科婦人科学 ⟩
徳島大学 ⟩ 病院 ⟩ 診療科 ⟩ 小児·周産·女性科 ⟩ 産科婦人科 ⟩
徳島大学 ⟩ 医学部 ⟩ 医学科 ⟩ 発生発達医学講座 ⟩ 産科婦人科学分野 ⟩

(researchmapへのインポート用ファイル) [PDF解説] [researchmapへの自動反映について]

研究活動

専門分野

研究テーマ

著書・論文

学術論文(審査論文):

1.	内芝舞実, 山本由理, 宮本容子, 吉田友紀子, 野口拓樹, 武田明日香, 湊沙希, 鎌田周平, 白河綾, 祖川英至, 峯田あゆか, 吉田あつ子, 加地剛, 苛原稔, 岩佐武 : 当院におけるART妊娠者でのNIPT受検率について, 徳島産婦人科医報, No.56, 3-7, 2023年.
2.	大西美嘉子, 吉田あつ子, 中川奉宇, 白河綾, 香川智洋, 峯田あゆか, 西村正人, 岩佐武, 加地剛 : 症例報告: 血栓症を発症した卵巣癌合併妊娠の2例, 現代産婦人科, Vol.72, No.1, 57-61, 2023年. (文献検索サイトへのリンク) ● CiNii @ 国立情報学研究所 (CRID): 1520580535991133824 (CiNii: 1520580535991133824)
3.	Akiko Abe, Masao Yuasa, Yoshie Imai, Tomohiro Kagawa, Ayuka Mineda, Masato Nishimura, Chisato Tonoiso, Akiko Kubo, Takashi Kawanaka, Hitoshi Ikushima and Takeshi Iwasa : Extreme leanness, lower skeletal muscle quality, and loss of muscle mass during treatment are predictors of poor prognosis in cervical cancer treated with concurrent chemoradiation therapy, International Journal of Clinical Oncology, Vol.27, No.5, 983-991, 2022. (要約) Human papillomavirus vaccination is not widespread in Japan, and the low screening rates result in many cases of locally advanced cervical cancer. We investigated the prognostic significance of sarcopenia in patients with cervical cancer to guide healthcare policies to improve treatment outcomes. This retrospective study included 83 patients with cervical cancer without distant metastasis who underwent primary concurrent chemoradiotherapy between 2013 and 2018. We analyzed the indicators of physical condition and muscle quantity using the SYNAPSE VINCENT software. Muscle mass and the relationship between treatment toxicity and prognosis were evaluated. The patients' median age was 60 (range 33-80) years. Cancer stage distribution was as follows: cT2b or higher, 84.3%; N1, 65.1%; and MA, 27.7%. The overall sarcopenia (skeletal muscle index [SMI] < 38.5) rate was 30.1%, and the rate was 33.9 and 22.2% in patients aged < 64 and ≥ 65 years, respectively. No correlation was observed between clinical stage and musculoskeletal indices. Treatment resulted in decreased body weight and SMI; after treatment, the sarcopenia rate increased to 37.3%. A higher intramuscular adipose tissue content (IMAC) reduced the number of chemotherapy cycles needed. Treatment-associated SMI decreases of ≥ 7% indicated poor prognosis, with significant differences in progression-free survival and overall survival (p = 0.013 and p = 0.012, respectively). Patients who were very lean (body mass index < 18.5 kg/m) before treatment had a poor prognosis (p = 0.016 and p < 0.001). Our findings emphasize the importance of assessing original nutritional status and maintaining muscle mass and quality during the treatment of patients with cervical cancer. (キーワード) Adult / Aged / Aged, 80 and over / Chemoradiotherapy / Female / Humans / Middle Aged / Muscle, Skeletal / Papillomavirus Infections / Papillomavirus Vaccines / Prognosis / Retrospective Studies / Sarcopenia / Thinness / Uterine Cervical Neoplasms (出版サイトへのリンク) ● Publication site (DOI): 10.1007/s10147-022-02140-w (文献検索サイトへのリンク) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35212828 ● Summary page in Scopus @ Elsevier: 2-s2.0-85125283470 (DOI: 10.1007/s10147-022-02140-w, PubMed: 35212828, Elsevier: Scopus)
4.	Ayuka Mineda, Masato Nishimura, Tomohiro Kagawa, Eri Takiguchi, Takako Kawakita, Akiko Abe and Minoru Irahara : Resveratrol suppresses proliferation and induces apoptosis of uterine sarcoma cells by inhibiting the Wnt signaling pathway., Experimental and Therapeutic Medicine, Vol.17, No.3, 2242-2246, 2019. (要約) Resveratrol, a natural product and peroxisome proliferator-activated receptor (PPAR) agonist, has been reported to exert anti-cancer effects in several tumor models. A previous study by our group reported that prostaglandin J2, a PPARγ ligand, inhibited cell proliferation in a uterine sarcoma cell line. The aim of the present study was to investigate the role of the Wnt signaling pathway in resveratrol-induced apoptosis and inhibition of cell proliferation in the MES-SA human uterine sarcoma cell line. A WST-1 assay demonstrated that resveratrol inhibited cell proliferation in the MES-SA cell line, and flow cytometry revealed that the number of apoptotic cells increased in a resveratrol dose-dependent manner. The mechanisms underlying these effects of resveratrol were speculated to involve the expression of β-catenin and its target gene, c-myc, which were examined using western blot analysis. The results revealed a dose-dependent downregulation of this β-catenin and c-myc. This effect was blunted by a pharmacological inhibitor of glycogen synthase kinase 3β. Therefore, it is likely that resveratrol inhibited the cell proliferation and increased the number of apoptotic cells, at least partially, via the Wnt signaling pathway. The present results suggest that resveratrol is a potential candidate for the treatment of uterine sarcoma. (徳島大学機関リポジトリ) ● Metadata: 113338 (出版サイトへのリンク) ● Publication site (DOI): 10.3892/etm.2019.7209 (文献検索サイトへのリンク) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 30867708 ● Search Scopus @ Elsevier (PMID): 30867708 ● Search Scopus @ Elsevier (DOI): 10.3892/etm.2019.7209 (徳島大学機関リポジトリ: 113338, DOI: 10.3892/etm.2019.7209, PubMed: 30867708)
5.	Masaharu Kamada, Hiroaki Inui, Tomohiro Kagawa, Ayuka Mineda, Takao Tamura, Tomohito Fujioka, Takahiro Motoki, Hiroki Hirai, Eiichi Ishii and Minoru Irahara : What information can change the attitude of teachers toward the human papillomavirus vaccine?, The Journal of Obstetrics and Gynaecology Research, Vol.44, No.4, 778-787, 2018. (要約) We conducted a self-administered survey on the perception of teachers toward human papillomavirus (HPV) vaccine to determine the ways to increase their willingness to encourage its use. Answers were obtained both prior to and after having the teachers read five brief information articles: (i) cervical cancer knowledge, (ii) vaccine knowledge, (iii) result of a survey in Nagoya, (iv) news report of the World Health Organization statement and (v) articles written by Dr Muranaka, a journalist. Most of the respondents (180/247) did not know about the natural history of cervical cancer. Only 36% knew that HPV is the cause of cervical cancer, although 63% knew that HPV vaccine would prevent cervical cancer. Few respondents had knowledge regarding adverse events following immunization and the survey results from Nagoya. Among those who were initially negative for the HPV vaccine, only 43% revealed that they fully understood its safety and only 29% reversed their opinion to recommend vaccination to their daughters and/or students, even after reading our informational material. The most useful information for changing their attitudes was to increase their understanding of vaccines and informing them about Nagoya city survey results. They mostly wanted a proof of the preventive effects of the vaccine on cervical cancer in Japan. Gynecologists and pediatricians must proactively communicate accurate scientific information to the government and the media to spread awareness among people in Japan. Also, we must try to demonstrate the capabilities of this vaccine to prevent cervical cancer and/or its precancerous lesions. (出版サイトへのリンク) ● Publication site (DOI): 10.1111/jog.13584 (文献検索サイトへのリンク) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 29442400 ● Search Scopus @ Elsevier (PMID): 29442400 ● Search Scopus @ Elsevier (DOI): 10.1111/jog.13584 (DOI: 10.1111/jog.13584, PubMed: 29442400)
6.	Eri Takiguchi, Masato Nishimura, Ayuka Mineda, Takako Kawakita, Akiko Abe and Minoru Irahara : Growth inhibitory effect of the Src inhibitor dasatinib in combination with anticancer agents on uterine cervical adenocarcinoma cells., Experimental and Therapeutic Medicine, Vol.14, No.5, 4293-4299, 2017. (要約) Uterine cervical adenocarcinoma has a poor clinical prognosis when compared with squamous cell carcinoma. Therefore, the development of new treatment strategies for uterine cervical adenocarcinoma is necessary. Src is a proto-oncogene that is important in cancer progression. Dasatinib is a Src inhibitor that has been reported to be effective when used in combination with anticancer drugs. The present study aimed to confirm Src expression in human cervical adenocarcinoma cell lines and to determine the mechanism underlying the inhibitory effect of dasatinib on Src signaling . Western blot analysis was performed to investigate Src expression in cervical adenocarcinoma cell lines (HeLa and TCO-2 cells). The cells were cultured for 48 h with the addition of different concentrations of anticancer drugs (paclitaxel or oxaliplatin). Viable cell count was measured using a colorimetric (WST-1) assay. The concentrations of anticancer agents were fixed according to the results obtained, and the same experiments were performed using the drugs in combination with dasatinib at various concentrations to determine the concentrations that significantly affected the number of viable cells. The presence or absence of apoptosis was investigated using a caspase-3/7 assay. Signal transduction in each cell line was examined using western blotting. Src was activated in the two cell lines, and cell proliferation was significantly suppressed by each anticancer drug in combination with 10 µM dasatinib. Caspase-3/7 activity was also increased and Src signaling was suppressed by each anticancer drug in combination with dasatinib. In conclusion, Src is overexpressed in cervical adenocarcinoma cell lines, and dasatinib inhibits intracellular Src signaling and causes apoptosis. The results of the present study suggest that Src may be targeted in novel therapeutic strategies for cervical adenocarcinoma. (徳島大学機関リポジトリ) ● Metadata: 112973 (出版サイトへのリンク) ● Publication site (DOI): 10.3892/etm.2017.5061 (文献検索サイトへのリンク) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 29067110 ● Search Scopus @ Elsevier (PMID): 29067110 ● Search Scopus @ Elsevier (DOI): 10.3892/etm.2017.5061 (徳島大学機関リポジトリ: 112973, DOI: 10.3892/etm.2017.5061, PubMed: 29067110)

学術論文(紀要・その他):

1.	大西美嘉子, 吉田あつ子, 中川奉宇, 白河綾, 香川智洋, 峯田あゆか, 西村正人, 岩佐武, 加地剛 : 血栓症を発症した卵巣癌合併妊娠の2例, 現代産婦人科, Vol.72, No.1, 57-61, 2023年.
2.	Takeshi Iwasa, Hiroki Noguchi, Risa Tanano, Erika Yamanaka, Asuka Takeda, Kou Tamura, Hidenori Aoki, Tatsuro Sugimoto, Hikari Sasada, Takaaki Maeda, Saki Minato, Shota Yamamoto, Hiroaki Inui, Tomohiro Kagawa, Atsuko Yoshida, Ayuka Mineda, Mari Nii, Riyo Kinouchi, Kanako Yoshida, Yuri Yamamoto and Takashi Kaji : Age-Dependent Changes in the Effects of Androgens on Female Metabolic and Body Weight Regulation Systems in Humans and Laboratory Animals., International Journal of Molecular Sciences, Vol.24, No.23, 16567, 2023. (要約) In recent years, the effects of androgens on metabolic and body weight regulation systems and their underlying mechanisms have been gradually revealed in females. In women and experimental animals of reproductive age, androgen excess can adversely affect metabolic functioning, appetite, and body weight regulation. In addition, excess androgens can increase the risk of metabolic disorders, such as obesity, insulin resistance, and diabetes. These unfavorable effects of androgens are induced by alterations in the actions of hypothalamic appetite-regulatory factors, reductions in energy expenditure, insulin resistance in skeletal muscle, and β-cell dysfunction. Interestingly, these unfavorable effects of androgens on metabolic and body-weight regulation systems are neither observed nor evident in ovariectomized animals and post-menopausal women, indicating that the adverse effects of androgens might be dependent on the estrogen milieu. Recent findings may provide novel sex- and age-specific strategies for treating metabolic diseases. (キーワード) Animals / Humans / 女性 (female) / Androgens / Insulin Resistance / Obesity / Metabolic Diseases / Animals, Laboratory / Polycystic Ovary Syndrome (出版サイトへのリンク) ● Publication site (DOI): 10.3390/ijms242316567 (文献検索サイトへのリンク) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 38068890 ● Search Scopus @ Elsevier (PMID): 38068890 ● Search Scopus @ Elsevier (DOI): 10.3390/ijms242316567 (DOI: 10.3390/ijms242316567, PubMed: 38068890)
3.	Naoto Yonetani, Takashi Kaji, Aya Shirakawa, Eishi Sogawa, Atsuko Yoshida, Ayuka Mineda, Kazuhisa Maeda, Minoru Irahara and Takeshi Iwasa : Sonographic confirmation of placental detachment during placental delivery for uterine inversion prevention., The Journal of Obstetrics and Gynaecology Research, Vol.49, No.11, 2644-2648, 2023. (要約) Five thousand and eighty-one women, including 1724 and 3357 women who delivered before and after the ultrasonography was introduced, respectively. The frequency of uterine inversion after the introduction of the ultrasonography system was significantly reduced compared to that before the introduction (0.03% vs. 0.23%, p = 0.03). Even after the introduction of ultrasonography, the actual rate of performing ultrasonography remained 54.1% due to various restrictions. The mean duration of the third stage of labor in the USG group was slightly longer than that in the non-USG group (8.4 ± 5.0 vs. 6.8 ± 3.6, p < 0.01). The mean bleeding volume during labor in the USG group was higher compared with the non-USG group (457 ± 329 vs. 418 ± 285, p < 0.01). (キーワード) Pregnancy / Female / Humans / Placenta / Uterine Inversion / Retrospective Studies / Ultrasonography / Delivery, Obstetric / Obstetric Labor Complications (出版サイトへのリンク) ● Publication site (DOI): 10.1111/jog.15763 (文献検索サイトへのリンク) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37551066 ● Search Scopus @ Elsevier (PMID): 37551066 ● Search Scopus @ Elsevier (DOI): 10.1111/jog.15763 (DOI: 10.1111/jog.15763, PubMed: 37551066)
4.	Junki Imaizumi, Shuhei Kamada, Miyu Taniguchi, Tatsuro Sugimoto, Takaaki Maeda, Ryosuke Arakaki, Shota Yamamoto, Aya Shirakawa, Ayuka Mineda, Atsuko Yoshida, Takeshi Iwasa and Takashi Kaji : Developmental Changes in Hypothalamic and Serum Oxytocin Levels in Prenatally Normally Nourished and Undernourished Rats., Nutrients, Vol.15, No.12, 2768, 2023. (要約) Changes in the activities of some metabolic factors have been suggested to increase the risk of conditions associated with the Developmental Origins of Health and Disease (DOHaD). We examined changes in oxytocin (OT), a metabolic factor, and OT receptor (OTR) mRNA levels throughout the developmental period in rats of intrauterine undernutrition. Pregnant rats were divided into two groups: a maternal normal nutrition (mNN) and maternal undernutrition (mUN) group. Serum OT concentrations and hypothalamic mRNA levels of OT and OTR were measured in both offspring at various postnatal stages. Both offspring showed significant increases in serum OT concentrations during the neonatal period, significant reductions around the pubertal period, and significant increases in adulthood. Hypothalamic OT mRNA expression levels gradually increased from the neonatal to pubertal period and decreased in adulthood in both offspring. In the pre-weaning period, hypothalamic OT mRNA expression levels were significantly lower in the mUN offspring than in the mNN offspring. In the mUN offspring, hypothalamic OTR mRNA expression levels transiently increased during the neonatal period, decreased around the pubertal period, and increased again in adulthood, whereas transient changes were not detected in mNN offspring. These changes could affect nutritional and metabolic regulation systems in later life and play a role in the mechanisms underlying DOHaD. (キーワード) Pregnancy / Female / Rats / Animals / Oxytocin / Rats, Sprague-Dawley / Malnutrition / Weaning / RNA, Messenger (出版サイトへのリンク) ● Publication site (DOI): 10.3390/nu15122768 (文献検索サイトへのリンク) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37375670 ● Search Scopus @ Elsevier (PMID): 37375670 ● Search Scopus @ Elsevier (DOI): 10.3390/nu15122768 (DOI: 10.3390/nu15122768, PubMed: 37375670)
5.	篠原文香, 峯田あゆか, 乾宏彰, 香川智洋, 阿部彰子, 西條康代, 西村正人, 苛原稔, 岩佐武 : 術前に卵巣原発胚細胞性腫瘍を疑ったが, 傍卵巣の平滑筋肉腫であった一例, 現代産婦人科, Vol.70, No.1, 227-231, 2021年. (キーワード) 骨盤内腫瘍 / 平滑筋肉腫 / 画像評価 / 栄養血管 / pelvic tumor / leiomyosarcoma / image evaluation / feeding blood vessels / コツバンナイシュヨウ / ヘイカツキンニクシュ / ガゾウヒョウカ / エイヨウケッカン (文献検索サイトへのリンク) ● CiNii @ 国立情報学研究所 (CRID): 1520290885604307712 (CiNii: 1520290885604307712)
6.	阿部彰子, 香川智洋, 祖川英至, 峯田あゆか, 西村正人 : 生殖年齢期に発生した子宮内膜癌・異型内膜増殖症におけるミスマッチ修復蛋白発現に関する検討, 遺伝性腫瘍, Vol.20, No.3, 146-150, 2020年. (要約) <p>妊孕性温存療法希望の早期子宮体癌および異型内膜増殖症症例にMPA療法を行うも不応や再燃症例も経験する．徳島大学産科婦人科で初回治療を行った若年子宮体癌および異型内膜増殖症21症例を対象にミスマッチ修復(mismatch repair;MMR)蛋白発現と，MPA療法の効果，再燃リスク，および予後との関連について検討した．MMR蛋白の発現欠失は7例で認め，MLH1欠失4例，PMS2欠失5例，MSH2欠失2例，MSH6欠失2例であった．リンパ節転移例と再発原病死例はいずれもMLH1欠失例であった．MPA療法施行13例中，MMR欠失を2例で認めたが，いずれもMPA奏効・無病生存例であった．初回治療後，異時性卵巣癌発症を2例に認め，このうちの1例はPeutz-Jeghers症候群であった．本検討では対象例が少なく，MMR蛋白発現とMPA療法の効果および再燃リスクとの間に有意な関連は確認できなかった．しかしMMR欠失を認めなくとも，遺伝性疾患を背景にもつハイリスク症例もあり，家族歴を考慮した適切な医学的管理が必要であると考えられた．</p> (キーワード) 子宮体癌 / ミスマッチ修復機構欠損 / 遺伝性腫瘍 (出版サイトへのリンク) ● Publication site (DOI): 10.18976/jsht.20.3_146 (文献検索サイトへのリンク) ● CiNii @ 国立情報学研究所 (CRID): 1390286981364673792 ● Search Scopus @ Elsevier (DOI): 10.18976/jsht.20.3_146 (DOI: 10.18976/jsht.20.3_146, CiNii: 1390286981364673792)
7.	香川智洋, 阿部彰子, 乾宏彰, 峯田あゆか, 西村正人 : 嚢胞状帝王切開瘢痕部が着床部結節から成っていた一例, 現代産婦人科, Vol.69, No.1, 5-9, 2020年. (キーワード) 帝王切開瘢痕症候群 / 中間型栄養膜細胞 / 着床部結節 (文献検索サイトへのリンク) ● CiNii @ 国立情報学研究所 (CRID): 1520572359820341376 (CiNii: 1520572359820341376)

国際会議:

1.	Akiko Abe, Akira Kuwahara, Tomohiro Kagawa, Ayuka Mineda and Masato Nishimura : A survey of germline mutations with epithelial ovarian cancer in Japanese patients., ESGO Annual Meeting 2019, Greece, Nov. 2019.

国内講演発表:

1.	Hiroshi Miyamoto, Ayuka Mineda, Sawaka Yukishige, Soichiroh Sasa, Kei Daizumoto, Tomoya Fukawa, Yasuyuki Okada, Yasuhiro Mitsui, Koichi Okamoto, Yasushi Sato, Hiroyuki Morino and Tetsuji Takayama : Management of patients with presumed germline pathogenic variant from comprehensive genomic profiling tests., 日本人類遺伝学会第69回大会, Oct. 2024.
2.	吉田あつ子, 加地剛, 中川奉宇, 白河綾, 峯田あゆか, 菅野幹雄, 早渕康信, 岩佐武 : 手術を要した単独VSDの胎児診断および出生後診断についての検討, 第97回日本超音波医学会学術集会, 2024年5月.
3.	乾宏彰, 西村正人, 新垣亮輔, 香川智洋, 峯田あゆか, 吉田加奈子, 加藤剛志, 岩佐武 : 当院で診断的円錐切除術を施行した子宮頸癌合併妊娠2例の子宮頸部細胞診についての検討, 徳島臨床細胞学会学術集会, 2024年3月.
4.	木内理世, 加藤剛志, 武田明日香, 新垣亮輔, 内芝舞実, 香川智洋, 白河綾, 峯田あゆか, 山本由理, 吉田加奈子, 岩佐武 : 前方シングルメッシュによるLSCまたはRSCによるPーQOLの改善についての検討, 第75回中国四国産科婦人科学会総会ならびに学術講演会, 2023年9月.
5.	木内理世, 加藤剛志, 武田明日香, 新垣亮輔, 内芝舞実, 香川智洋, 白河綾, 峯田あゆか, 山本由理, 吉田加奈子, 岩佐武 : 前方シングルメッシュによるLSCまたはRSCによるP-QOLの改善についての検討, 第63回日本産科婦人科内視鏡学会学術講演会, 2023年9月.
6.	加地剛, 白河綾, 峯田あゆか, 吉田あつ子, 須賀健一, 中川竜二, 高橋正幸, 岩佐武 : 胎児期の一過性の陰茎先端部の狭窄により片側腎臓の低形成を来した1例, 第32回日本小児泌尿器科学会総会・学術集会, 2023年7月.
7.	大西美嘉子, 加地剛, 白河綾, 峯田あゆか, 吉田あつ子, 須賀健一, 中川竜二, 岩佐武 : 胎児心拡大および冠動脈血流速度上昇が診断の契機になった一過性骨髄異常増殖症の一例, 第59回日本周産期・新生児医学会総会・学術集会, 2023年7月.
8.	加地剛, 中川奉宇, 吉田あつ子, 白河綾, 峯田あゆか, 菅野幹雄, 早渕康信, 岩佐武 : ポスタ-発表胎児2 手術を要した単独VSDの胎児診断および出生後診断についての検討, 第59回日本小児循環器学会総会·学術集会, 2023年7月.
9.	吉田加奈子, 加藤剛志, 武田明日香, 新垣亮輔, 今泉絢貴, 香川智洋, 峯田あゆか, 河北貴子, 山本由理, 苛原稔, 岩佐武 : ワークショップ:効率よくTLH上達を目指すための当科での取り組み, 第62回日本産婦人科内視鏡学会, 2022年9月.
10.	吉田加奈子, 門田友里, 笠井可菜, 峯田あゆか, 河北貴子, 加藤剛志, 西村正人, 苛原稔, 岩佐武 : 腹腔鏡下仙骨腟固定術(LSC)における後腹膜閉鎖の工夫, 第60回日本産婦人科内視鏡学会学術講演会, 2020年12月.
11.	岩佐武, 松崎利也, 阿部彰子, 柳原理江, 山本由理, 香川智洋, 峯田あゆか, 西村正人, 桑原章, 苛原稔 : 子宮内膜異型増殖症・初期子宮体癌患者に対する黄体ホルモン療法の治療成績，妊娠成績および周産期予後, 第72回中国四国日本産科婦人科学会学術講演会, 2019年9月.
12.	香川智洋, 阿部彰子, 峯田あゆか, 西村正人 : 嚢胞状帝王切開瘢痕部が着床部結節からなっていた一例, 第72回中国四国日本産科婦人科学会学術講演会, 2019年9月.
13.	阿部彰子, 井本逸勢, 香川智洋, 峯田あゆか, 西村正人, 苛原稔 : 上皮性卵巣癌に対する遺伝学的検査への意識調査とHRD遺伝子変異の検討, 第61回日本婦人科腫瘍学会, 2019年7月.
14.	西村正人, 峯田あゆか, 阿部彰子, 吉田加奈子, 加藤剛志, 苛原稔 : 若年におけるHPVワクチン接種は子宮頸癌検診における細胞診異常の頻度を低下させる, 第60回日本臨床細胞学会学術講演会, 2019年6月.

科学研究費補助金 (KAKEN Grants Database @ NII.ac.jp)

研究者番号（20936877）による検索